SA/CS-CaCl2/PMCG微胶囊的生物相容性研究

介绍了一种新型多组份生物微胶囊体系－SA／CS－CaCl2/PMCG微胶囊。考察了PMCG和SA／CS－CaCl2/PMCG微胶囊体系对大肠杆菌和酿酒酵母生长的影响,并用SA／CS－CaCl2/PMCG微胶囊进行了固定化培养大肠杆菌和酿酒酵母的研究。结果表明,与其它合成聚阳离子类似,PMCG组分对细胞生长有明显的抑制作用,但是在制胶囊过程中以及在用SA／CS－CaCl2/PMCG微胶囊对大肠杆菌和酿酒酵母培养过程中,都显示了良好的生物相容性,因此作为整个体系来说,该微胶囊可用于微生物细胞的固定化培养。     

Improvement of the stability of glucose oxidase via encapsulation in sodium alginate–cellulose sulfate–poly(methylene-co-guanidine) capsules

Encapsulation of glucose oxidase (GOD) in polyelectrolyte complex capsules and its influence on properties of the enzyme is reported. The immobilization of GOD in the capsules made of sodium alginate (SA), cellulose sulfate (CS), poly(methylene-co-guanidine) (PMCG), CaCl₂ and NaCl (GOD–SA–CS/PMCG capsules) was achieved using a one-step highly reproducible encapsulation protocol which was monitored by a Electrospray Ionization-Mass Spectrometry (ESI-MS). A leakage of the enzyme from the capsules was negligible. Encapsulated GOD exhibited higher thermostability, wider range of pH optimum and improved storage stability in comparison with free GOD. The 92% retained activity by the encapsulated GOD after 45 biooxidation cycles was markedly higher than that of the GOD entrapped in calcium pectate gel beads showing no activity after 12 cycles. Optimization of conditions of oxygen supplementation resulted in increased oxygen availability within the GOD–SA–CS/PMCG capsules. Oxygen supplementation was accompanied with a mild decrease in the mechanical resistance of the SA–CS/PMCG capsules.     

Short Synthesis and Antiviral Activity of Acyclic Phosphonic Acid Nucleoside Analogues

An efficient route for synthesizing novel allylic and cyclopropanoid phosphonic acid nucleoside analogues is described. The condensation of the bromine derivatives 6 and 18 with nucleoside bases (A, U, T, C, G) under standard nucleophilic substitution and deprotection conditions, afforded the target phosphonic acid nucleoside analogues. These compounds were evaluated for their antiviral properties against various viruses. Cyclopropanoid phosphonic adenine nucleoside analogue 23 showed significant anti-HIV activity.